RecruitingPsoriasis
Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
4 weeks of adjunctive therapy of Enstilar® QD followed by 12 weeks QOD to patients with 2-10% BSA who are receiving etanercept or adalimumab for at least 24 weeks
Sponsor: Psoriasis Treatment Center of Central New Jersey
You may qualify if…
- ✓ Male or female adult ≥ 18 years of age;
- ✓ Diagnosis of chronic plaque-type
- ✓ Patient with 2-10% BSA
- ✓ Physician Global Assessment of 2 or greater
- ✓ Patient has been treated with etanercept or adalimumab for a minimum of 24 weeks
You may not qualify if…
- ✕ ˂2 or \>10% BSA
- ✕ PGA \<2
- ✕ Patient not receiving etanercept or adalimumab, or receiving etanercept or adalimumab \<24weeks
Where it's recruiting
New Jersey
East Windsor
Source: ClinicalTrials.gov · NCT03827876 · last updated 2019-02-04